一种用于原位转染 BMP-7 和 VEGF-A 的生物活性纳米磷酸钙糊剂在兔临界尺寸骨缺损中的应用:一项体内研究结果。
A bioactive nano-calcium phosphate paste for in-situ transfection of BMP-7 and VEGF-A in a rabbit critical-size bone defect: results of an in vivo study.
机构信息
Department of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Inorganic Chemistry and Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, Universitaetsstr. 5-7, 45117, Essen, Germany.
出版信息
J Mater Sci Mater Med. 2019 Jan 22;30(2):15. doi: 10.1007/s10856-019-6217-y.
The aim of this study was to prepare an injectable DNA-loaded nano-calcium phosphate paste that is suitable as bioactive bone substitution material. For this we used the well-known potential of calcium phosphate in bone contact and supplemented it with DNA for the in-situ transfection of BMP-7 and VEGF-A in a critical-size bone defect. 24 New Zealand white rabbits were randomly divided into two groups: One group with BMP-7- and VEGF-A-encoding DNA on calcium phosphate nanoparticles and a control group with calcium phosphate nanoparticles only. The bone defect was created at the proximal medial tibia and filled with the DNA-loaded calcium phosphate paste. As control, a bone defect was filled with the calcium phosphate paste without DNA. The proximal tibia was investigated 2, 4 and 12 weeks after the operation. A histomorphological analysis of the dynamic bone parameters was carried out with the Osteomeasure system. The animals treated with the DNA-loaded calcium phosphate showed a statistically significantly increased bone volume per total volume after 4 weeks in comparison to the control group. Additionally, a statistically significant increase of the trabecular number and the number of osteoblasts per tissue area were observed. These results were confirmed by radiological analysis. The DNA-loaded bone paste led to a significantly faster healing of the critical-size bone defect in the rabbit model after 4 weeks. After 12 weeks, all defects had equally healed in both groups. No difference in the quality of the new bone was found. The injectable DNA-loaded calcium phosphate paste led to a faster and more sustained bone healing and induced an accelerated bone formation after 4 weeks. The material was well integrated into the bone defect and new bone was formed on its surface. The calcium phosphate paste without DNA led to a regular healing of the critical-size bone defect, but the healing was slower than the DNA-loaded paste. Thus, the in-situ transfection with BMP-7 and VEGF-A significantly improved the potential of calcium phosphate as pasty bone substitution material.
本研究旨在制备一种可注射的负载 DNA 的纳米磷酸钙糊剂,作为生物活性骨替代材料。为此,我们利用磷酸钙在骨接触中的已知潜力,并补充了 DNA,以便在临界尺寸骨缺损中就地转染 BMP-7 和 VEGF-A。24 只新西兰白兔被随机分为两组:一组用负载 DNA 的磷酸钙纳米颗粒,一组只用磷酸钙纳米颗粒。在胫骨近端内侧造成骨缺损,并填充负载 DNA 的磷酸钙糊剂。作为对照,在没有 DNA 的情况下,用磷酸钙糊剂填充骨缺损。术后 2、4 和 12 周,对近侧胫骨进行了研究。使用 Osteomeasure 系统对动态骨参数进行了组织形态学分析。与对照组相比,负载 DNA 的磷酸钙治疗的动物在 4 周后,总骨体积中的骨体积分数有统计学显著增加。此外,还观察到骨小梁数量和组织面积内成骨细胞数量的统计学显著增加。放射学分析也证实了这一结果。负载 DNA 的骨糊在 4 周后导致兔模型中的临界尺寸骨缺损愈合明显加快。12 周后,两组的所有缺损均愈合良好。未发现新骨质量的差异。负载 DNA 的可注射磷酸钙糊剂在 4 周后导致更快、更持续的骨愈合,并在 4 周后诱导更快的骨形成。该材料很好地整合到骨缺损中,在其表面形成新骨。不含 DNA 的磷酸钙糊剂导致临界尺寸骨缺损的正常愈合,但愈合速度比负载 DNA 的糊剂慢。因此,BMP-7 和 VEGF-A 的原位转染显著提高了磷酸钙作为糊剂骨替代材料的潜力。